Breast Cancer Clinical Trial

Ask Questions (ASQ):Implementation of a Communication Intervention

Summary

This clinical trial implements a communication intervention to improve patient-oncologist communication in the outpatient medical oncology setting. A communication brochure called the ASQ brochure may help patients prepare for the doctor visit by thinking through the questions that patients and patients' family want to ask the doctor.

View Full Description

Full Description

Patient-centered communication is critical to providing high-quality care. In patient-provider clinical interactions, providers are responsible for several aspects of patient-centered communication. However, to reach the goal of providing the best possible treatments, patients should also actively participate by asking questions and expressing their concerns. Question prompt lists, simple lists of questions provided to patients before clinic visits to help them prepare for the appointment, have been tested in several medical contexts and patient populations, including among an underserved, minority population in Detroit, and have been shown to contribute to improved outcomes related to better communication quality. Using a RE-AIM framework, this descriptive, mixed methods, single-arm intervention study assesses the implementation of an evidence-based communication intervention (question prompt list), the "ASQ brochure". The ASQ brochure is designed to improve patient-oncologist communication and other outcomes by improving patient self-efficacy for managing patient-physician interactions. Investigators will recruit 225 patients and implement the ASQ brochure at seven Karmanos Cancer Center network sites. Participants are newly diagnosed patients with (Stages I-IV) cancer for which systemic therapy is likely a recommended treatment.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Adults 18 years of age or older
Have a first appointment to see a medical oncologist at a Karmanos Cancer Institute (KCC) site for medical/systemic treatment for a new, confirmed diagnosis of stages I-IV cancer
Speak and read English well enough to be able to understand consent documents
Given the diverse population seen at KCI, we will make attempts to recruit a representative sample. Our strategy will be simply to ask recruiters to make special attempts to recruit a representative sample. If that strategy fails after the first 10 patients we will build in requirements that at least 25% of the patients self-identify as non-White

Exclusion Criteria:

Not specified

Study is for people with:

Breast Cancer

Estimated Enrollment:

225

Study ID:

NCT05025748

Recruitment Status:

Recruiting

Sponsor:

Barbara Ann Karmanos Cancer Institute

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 8 Locations for this study

See Locations Near You

Karmanos Cancer Institute at McLaren Bay Region
Bay City Michigan, 48706, United States More Info
Susan Eggly, PhD
Contact
313-576-8260
Karmanos Cancer Institute at McLaren Clarkston
Clarkston Michigan, 48346, United States More Info
Susan Eggly, PhD
Contact
313-576-8260
Karmanos Cancer Institute
Detroit Michigan, 48201, United States More Info
Susan Eggly, Ph.D.
Contact
313-576-8260
Susan Eggly, Ph.D.
Principal Investigator
Lauren Hamel, Ph.D.
Sub-Investigator
Seongho Kim, Ph.D
Sub-Investigator
Voncile Brown-Miller, Ph.D
Sub-Investigator
Karmanos Cancer Institute at McLaren Flint
Flint Michigan, 48532, United States More Info
Susan Eggly, PhD
Contact
313-576-8260
Karmanos Cancer Institute at McLaren Macomb
Mount Clemens Michigan, 48043, United States More Info
Susan Eggly, PhD
Contact
313-576-8260
Karmanos Cancer Institute at McLaren Central Michigan
Mount Pleasant Michigan, 48858, United States More Info
Susan Eggly, PhD
Contact
313-576-8260
Karmanos Cancer Institute at McLaren Northern Michigan
Petoskey Michigan, 49770, United States More Info
Susan Eggly, PhD
Contact
313-576-8260
Karmanos Cancer Institute at McLaren Port Huron
Port Huron Michigan, 48060, United States More Info
Susan Eggly, PhD
Contact
313-576-8260

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

225

Study ID:

NCT05025748

Recruitment Status:

Recruiting

Sponsor:


Barbara Ann Karmanos Cancer Institute

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.